SISB INVESTMENT ADVISERS (UK) LTD
Institutional investor · Portfolio as of Q4 2022
Top Holdings14 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
COUPANG INC | 426.2M | $6.3B | 52.3% | $48.75 | -69.83% | 8 qtrssince 2021-Q1 | Decreased 0 |
GRAB HOLDINGS LTD - CL A | 709.3M | $2.3B | 19.1% | $7.08 | -54.55% | 5 qtrssince 2021-Q4 | Unchanged 0 |
DOORDASH INC - A | 21M | $1B | 8.6% | $140.20 | -65.18% | 9 qtrssince 2020-Q4 | Decreased 0 |
ROIVANT SCIENCES LTD | 95M | $759.3M | 6.3% | $10.64 | -24.91% | 5 qtrssince 2021-Q4 | Decreased 0 |
VIR BIOTECHNOLOGY INC | 20.3M | $512.8M | 4.3% | $12.12 | +108.83% | 13 qtrssince 2019-Q4 | Decreased 0 |
RELAY THERAPEUTICS INC | 27.9M | $416.9M | 3.5% | $39.98 | -62.63% | 10 qtrssince 2020-Q3 | Unchanged 0 |
COMPASS INC | 132.4M | $308.4M | 2.6% | $13.50 | -82.74% | 7 qtrssince 2021-Q2 | Unchanged 0 |
WEWORK INC | 81.1M | $115.9M | 1.0% | — | — | 5 qtrssince 2021-Q4 | Unchanged 0 |
FULL TRUCK ALLIANCE CO LTD | 8.7M | $69.9M | 0.6% | $7.07 | +9.97% | 2 qtrssince 2022-Q3 | Increased 70 |
VIEW INC | 66.2M | $63.9M | 0.5% | — | — | 8 qtrssince 2021-Q1 | Unchanged 0 |
ENERGY VAULT HOLDINGS INC | 18.5M | $57.8M | 0.5% | $9.89 | -68.45% | 3 qtrssince 2022-Q2 | Unchanged 0 |
AURORA INNOVATION INC | 39.4M | $47.7M | 0.4% | $11.41 | -89.40% | 5 qtrssince 2021-Q4 | Unchanged 0 |
Ginkgo Bioworks Holdings, Inc. | 24.4M | $41.3M | 0.3% | — | — | — | — |
Getaround, Inc. | 21.5M | $14M | 0.1% | $0.65 | 0.00% | 1 qtr | New 49 |
SB INVESTMENT ADVISERS (UK) LTD manages $12B across 14 positions as of Q4 2022. Top holdings: CPNG (52.3%), GRAB (19.1%), DASH (8.6%). Fund DNA: Concentrated Value. HoldingsIntel Rating: 2/5.0.
Added 2 new positions, exited 1, increased 1, trimmed 4. Top move: YMM (INCREASED, conviction 70). Portfolio: $12.0B across 14 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
No active accumulation streaks detected for this filer.
Streaks require 2+ consecutive quarters of increased positions in the most recent period.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer